Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe Asthenia
Status:
Unknown status
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to estimate the efficiency at 3 months of dexamfetamine
sulphate on the MFI 20 scale in severe fatigue of patients with stabilized gliomas.